Healthcare & Life Sciences
Paradox Immunotherapeutics
United Stateswww.paradoximmuno.com/
Paradox Immunotherapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Paradox Immunotherapeutics
Based in the United States, Paradox Immunotherapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Paradox Immunotherapeutics develops monoclonal antibody therapies that selectively target misfolded proteins to treat protein misfolding diseases such as amyloidosis and neurodegenerative disorders.
Explore Paradox Immunotherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.